Recruiting
Mobile App Logging for Diabetes in Pregnancy
To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.
ClinicalTrials.gov IDNCT06005987
PhaseNA
Enrollment40
SponsorCarolyn Zahler-Miller
Age18 Years and older
SexFEMALE
Conditions studied
Gestational Diabetes Mellitus in Pregnancy, Type 2 Diabetes
About this study
To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.
Interventions
- Behavioral: OneTouch Reveal application — Evaluate if compliance with glucose logging and percentage of in range glucoses changes with use of a mobile application instead of paper logging
Primary outcomes
- Compliance (4 weeks)
Eligibility information
Inclusion Criteria:
* 18 years and older
* Verified intrauterine pregnancy
* At least 12 weeks gestation
* Diagnosed with either type 2 diabetes mellitus or gestational diabetes mellitus.
Exclusion Criteria:
* Patients with less than 4 weeks anticipated to be remaining in pregnancy
* Pre-existing use of a continuous glucose monitor or other mobile application for glucose tracking
* Type 1 diabetes mellitus
* Non-English speaking patients
Study locations
- Augusta University, Augusta, Georgia 30912 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-28.